Duchenne, one of the most severe forms of muscular dystrophy, affects about one out of every 3,600 boys. The inherited rare ...

The delay on gambling advertising reform is apparently in the service of 'good policy design'. What does that tell us about ...

Blocking these TLR drivers is expected to disrupt the pathological re-enforcing cycle of inflammation and neurodegeneration leading to slowing of disease progression and improvement of symptoms. Eos ...

Researchers from King's College London, in collaboration with academics from Imperial College London, are exploring whether ...

New experimental studies by numerous research groups, including the Max Planck Institute for Evolutionary Biology (MPI-EB) in ...

Activating certain neurons during fertile phases set off rejection behavior, while silencing them in non-receptive females ...

A burgeoning number of studies are examining pediatric health equity, diversity, and inclusion (EDI). But if not done right, ...

Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, recently partnered with Solu Therapeutics (Solu) and is pleased to announce the ...

MDCX READ THE FULL V.MDCX RESEARCH REPORT IPO in U.S. Provides Additional Funding & Common Stock that Trades on Nasdaq On ...

New therapies could prevent the adjustments in intestinal bacteria that enable them to survive in inflamed regions ...

Moderna’s top executives have sought to reassure investors they will be able to carry out the comeback plans announced in ...

The Digital Health Advisory Committee (DHAC) held its first meeting to offer guidance to the FDA on a slew of questions ...